Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Veterinarian examining a dog with a diagnostic tool in a pet boarding facility

May 26, 2026

FinTech Pet Care Software Kennel Connection Brings Petwealth Pet Health Diagnostics to Pet Boarding & Daycare Expo West Following Strong Industry Reception at Intergroom

Kennel Connection is showcasing its partnership with Petwealth at the Pet Boarding & Daycare Expo West, following a successful introduction at Intergroom. This collaboration aims to enhance pet health diagnostics for boarding facilities and daycare operators.The recent Pet Boarding & Daycare Expo West in Phoenix marks a significant step for Kennel Connection, which is leveraging its exclusive partnership with Petwealth to offer advanced diagnostic tools. This initiative was well-received at Inte
A compliance document and pen on a wooden desk in a dimly lit office.

May 26, 2026

Beyond Digital: The Future of AI-Powered Life Sciences Compliance

The life sciences sector is undergoing a transformative shift towards AI-powered compliance, emphasizing efficiency while navigating regulatory challenges.The article discusses the increasing importance of artificial intelligence in enhancing compliance within the life sciences industry. As organizations evolve from basic digital systems to more intelligent operations, the integration of AI is seen as a strategic necessity. ValGenesis, a leader in digital validation, is organizing the ValConnect
A minimalist illustration of a lymph node and a cancer cell in a dark palette.

May 26, 2026

Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing

Caris Life Sciences has launched the "Behind the Diagnosis" campaign to highlight the transformative impact of its genomic testing on patient care.The inaugural story features Erika Rios, whose initial diagnosis of stage 4 metastatic triple-negative breast cancer was corrected through Caris GPSai, an AI-driven tissue-of-origin model. This innovative tool revealed her actual condition as Hodgkin lymphoma, a significantly more treatable cancer. The case underscores the importance of accurate molec
A vial of a drug compound on a lab countertop

May 26, 2026

Pharma 4.0 Market Research and Growth Analysis Report 2026-2033

The Pharma 4.0 market is set for significant expansion, fueled by advanced technologies like AI, IoT, and blockchain, which are transforming pharmaceutical manufacturing and personalizing medicine.The global Pharma 4.0 market is expected to grow from USD 15.0 billion in 2025 to USD 61.7 billion by 2033, representing a compound annual growth rate (CAGR) of 19.5%. This growth is primarily driven by the increasing integration of innovative technologies aimed at improving efficiency, regulatory comp
A minimalist illustration of a pill bottle and a pill on a solid background.

May 26, 2026

LSPedia Secures Investment to Fuel AI-Driven Pharma Supply Chain

LSPedia has secured a significant investment aimed at enhancing its AI-driven solutions for pharmaceutical supply chains, marking a shift from mere compliance to a more predictive and automated model that addresses critical industry challenges.Recently, LSPedia, a prominent player in pharmaceutical supply chain software, received a strategic growth investment from Bregal Sagemount. This funding is intended to help LSPedia evolve its operations beyond regulatory compliance, focusing instead on cr
A petri dish with a biological sample on a lab bench

May 26, 2026

Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science

Insilico Medicine and Human Longevity have embarked on a groundbreaking collaboration to develop the first large-scale AI foundation model focused on human longevity science.This partnership aims to harness the power of artificial intelligence to decode the biological mechanisms of aging, with the goal of enhancing predictive healthcare. The global longevity market, currently valued at approximately $5.3 trillion, is expected to reach $8 trillion by 2030, driven by advancements in AI-driven drug
A banana peel on a lab countertop next to a petri dish in a dimly lit lab.

May 26, 2026

Artificial intelligence is thinking about life sciences and AI/bio convergence

Recent developments highlight the growing intersection of artificial intelligence and life sciences, driven by major tech companies' strategic initiatives.Leading technology firms are increasingly investing in the life sciences sector through various means such as acquisitions, new platform launches, partnerships, and key appointments. This trend underscores the significant convergence between AI technologies and biological sciences, which many experts believe could revolutionize fields like med
Minimalist illustration of a microscope representing AI-powered microscopy.

May 26, 2026

NIT Rourkela develops AI-powered microscopy for disease detection

Researchers at the National Institute of Technology (NIT), Rourkela have introduced an innovative AI-driven autofocusing microscopy technology aimed at enhancing biomedical diagnostics. This development could revolutionize the detection of diseases such as acute lymphoblastic leukaemia and malaria, making healthcare diagnostics more accessible and efficient in India.The new system, created in partnership with Glowvista Instruments, showcases the potential for rapid and precise imaging with minim
A flat illustration of a pathology slide with an AI brain overlay, symbolizing digital pathology.

May 26, 2026

Roche to Acquire PathAI to Expand Digital Pathology and AI Diagnostics

Roche has announced its intent to acquire PathAI for $750 million, aiming to enhance its digital pathology and AI diagnostic capabilities.The acquisition, which follows a partnership initiated in 2021, is designed to integrate PathAI’s advanced AI technologies and image management systems into Roche's laboratory workflows. This merger is expected to transition traditional manual processes to automated, AI-enhanced operations, thereby improving diagnostic efficiency and accuracy in pathology.By i
A clipboard with regulatory documents on a wooden desk in a clinical office

May 26, 2026

What’s changing in AI regulation for drug development

Recent regulatory developments are shifting the landscape for AI in drug development, as organizations pivot from experimentation to establishing robust AI systems that meet regulatory standards.On January 14, the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) released joint guiding principles aimed at defining good AI practices in drug development. These principles serve as a reference for integrating AI into regulated processes, emphasizing the need for risk-base
A flat illustration of a syringe with a droplet, representing drug development.

May 26, 2026

Novo Nordisk Bets on AI to Cut Drug Launch Timelines by Two-Thirds, Bengaluru Hub Takes Lead Role

Novo Nordisk is leveraging artificial intelligence to significantly reduce drug launch timelines, aiming for a two-thirds reduction in the process, according to a company executive. This initiative is part of the company's strategy to enhance its position in the growing obesity drug market.John Dawber, managing director for global business services, indicated that traditional timelines for drug launches, which could take up to a year and a half from the last patient visit to the first regulatory
Cold storage unit with pharmaceutical products in a dimly lit warehouse

May 26, 2026

How Digital Strategies Transform Pharma Supply Chains in 2026

The pharmaceutical supply chain is evolving rapidly, driven by the need for agility and compliance amid increasing operational complexities. As margins tighten, companies must adopt digital strategies to enhance performance and mitigate risks associated with regulatory pressures and geopolitical challenges.The article outlines how pharmaceutical leaders are leveraging digital transformation to optimize supply chain efficiency. Emphasizing Eliyahu Goldratt’s Theory of Constraints (TOC), it highli